pcyc360.client shareholder.com

Investor Relations - Pharmacyclics, Inc.

Pharmacyclics Inc. Nasdaq PCYC is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs. Currently, we have three candidates in clinical development and several molecules in preclinical development. Dec 4, 2014.

OVERVIEW

This domain pcyc360.client.shareholder.com presently has a traffic ranking of zero (the smaller the better). We have acquired two social communication accounts owned by this website.
Social Links
2

PCYC360.CLIENT.SHAREHOLDER.COM RANKINGS

This domain pcyc360.client.shareholder.com is seeing a alternation quantities of traffic all round the year.
Traffic for pcyc360.client.shareholder.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for pcyc360.client.shareholder.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for pcyc360.client.shareholder.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

WHAT DOES PCYC360.CLIENT.SHAREHOLDER.COM LOOK LIKE?

Desktop Screenshot of pcyc360.client.shareholder.com Mobile Screenshot of pcyc360.client.shareholder.com Tablet Screenshot of pcyc360.client.shareholder.com

PCYC360.CLIENT.SHAREHOLDER.COM HOST

We revealed that the main page on pcyc360.client.shareholder.com took zero milliseconds to download. I could not find a SSL certificate, so we consider this site not secure.
Load time
0 secs
SSL
NOT SECURE
Internet Protocol
0.0.0.0

PAGE TITLE

Investor Relations - Pharmacyclics, Inc.

DESCRIPTION

Pharmacyclics Inc. Nasdaq PCYC is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs. Currently, we have three candidates in clinical development and several molecules in preclinical development. Dec 4, 2014.

CONTENT

This domain states the following, "Nasdaq PCYC is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases." We observed that the web site said " Our pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs." It also stated " Currently, we have three candidates in clinical development and several molecules in preclinical development."

SEEK MORE BUSINESSES

PCYCATRE-DE-X-OULD-Y

Monday, July 31, 2006. LIT CHAQUE JOURS TES COMMENTAIRE. DIA QUI ES SPECIALISER POUR LES FOUS. EST POUR MES CHER CITOYEN EST CITOYENNE CI VOUS LISER CHAQUE JOUR CE QUE ECRIT CE FOUS. CA VEUT DIRE QUE VOUS-MEME VOUS ALLEZ ETRE MALADE MENTALE COMME LUI.

Bellevue IT

Technology solutions for the business of sport. Delivering technology solutions to allow organisations to turn data into information. With customers such as the International Olympic Committee, International Sailing Federation and several Australian National Bodies, BvIT understands the business of sport at a World level. BvIT delivers technology solutions all the way from grass roots volunteers and individual club members through to the highest levels of sport.

PCYC - Police Citizens Youth Clubs NSW

Join or Renew Your Membership to PCYC. There are many great reasons to join a PCYC - sports, activities, new friends, leadership development, and lots of great stuff to do. Participate in PCYC activities and programs. Help your Club elect and operate a Club Committee to promote PCYC activities.

Home - PCYC

Safer Drivers Course for Learners. PCYC People Exec and RGMs.

Ciências e tecnologia

Quarta-feira, 8 de dezembro de 2010. Record vai comprar o SBT. Domingo, 22 de agosto de 2010. Rede globo abusa mais uma vez. Repórter da Globo chama Mariah Carey de baleia. Renata Capucci ainda ficou revoltada com os fãs da norte-americana. Renata Capucci resolveu regular os quilos da cantora Mariah Carey. A jornalista Renata Capucci, repórter do Jornal Hoje. Ela usou a página que mantém na rede de microblogs para se expressar.